Twist Bioscience Corp
TWST - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.54B
Close$
$10.48
91.3% downside
Current Fair Value
91.3% downsideOvervalued by 91.3% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $7.54 Billion |
|---|---|
| Enterprise Value | $7.52 Billion |
| Earnings per Share | $-1.3 |
| Beta | 2.19 |
| Outstanding Shares | 62,403,000 |
Return
| Return on Equity | -30.67% |
|---|---|
| Return on Assets | -20.33% |
| Return on Invested Capital | -25.50% |
Valuation & Multiples
| P/E Ratio | -68.82 |
|---|---|
| PEG | 25.31 |
| Price to Sales | 20.13 |
| Price to Book Ratio | 17.26 |
| Enterprise Value to Revenue | 17.42 |
| Enterprise Value to EBIT | -53.41 |
| Enterprise Value to Net Income | -56 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.22 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 3, 2026
EPS Estimate
$-0.51
Consensus analyst estimateRevenue Estimate
$114.55 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.38
Consensus analyst estimateRevenue Estimate
$123.55 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 39.14% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.23%▼ 122.51% |
|---|---|
| Total Invested | $267.78M▼ 96.62% |
| Investors Holding | 94▼ 254.00% |
About Twist Bioscience Corp
CEO: Emily Leproust
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary techno...